Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
12.47 BRL | +4.35% | +3.06% | -9.18% |
Mar. 04 | Barclays Downgrades Ambev to Equalweight From Overweight, Adjusts Price Target to $3 From $3.50 | MT |
Feb. 29 | Transcript : Ambev S.A., Q4 2023 Earnings Call, Feb 29, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.18% | 38.43B | |
-5.03% | 119B | |
-2.59% | 55.05B | |
+6.18% | 46.85B | |
-2.87% | 22.69B | |
-21.89% | 19.14B | |
+8.95% | 19.09B | |
+3.25% | 17.99B | |
+9.80% | 15.43B | |
+15.74% | 12.92B |
- Stock Market
- Equities
- ABEV3 Stock
- News Ambev S.A.
- Ambev S A : Morgan Stanley Downgrades Ambev to Underweight from Equalweight